Clinical Trial Details
| Trial ID: | L6868 |
| Source ID: | NCT01686711 |
| Associated Drug: | Ad-4833 15 Mg |
| Title: | A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322 |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Mellitus |
| Interventions: | DRUG: AD-4833 15 mg|DRUG: AD-4833 30 mg|DRUG: Placebo |
| Outcome Measures: | Primary: Glycosylated Hemoglobin (HbA1c), Measurement of change in HbA1c (ratio of hemoglobin bound to glucose), 16 weeks | |
| Sponsor/Collaborators: | Sponsor: Takeda |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 207 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: |Intervention Model: PARALLEL|Masking: |Primary Purpose: TREATMENT |
| Start Date: | 2012-09 |
| Completion Date: | 2013-12 |
| Results First Posted: | |
| Last Update Posted: | 2023-08-31 |
| Locations: | Hirosaki-shi, Aomori, Japan|Kisaratsu-shi, Chiba, Japan|Matsuyama-shi, Ehime, Japan|Fukuoka-shi, Fukuoka, Japan|Kitakyushu-shi, Fukuoka, Japan|Kurume-shi, Fukuoka, Japan|Fukuyama-shi, Hiroshima, Japan|Hiroshima-shi, Hiroshima, Japan|Sapporo-shi, Hokkaido, Japan|Koga-shi, Ibaraki, Japan|Yokohama-shi, Kanagawa, Japan|Kumamoto-shi, Kumamoto, Japan|Miyazaki-shi, Miyazaki, Japan|Suita-shi, Osaka, Japan|Koshigaya-shi, Saitama, Japan|Otsu-shi, Shiga, Japan|Chiyoda-ku, Tokyo, Japan|Chuo-ku, Tokyo, Japan|Itabashi-ku, Tokyo, Japan|Meguro-ku, Tokyo, Japan|Minato-ku, Tokyo, Japan|Ohta-ku, Tokyo, Japan|Shinjuku-ku, Tokyo, Japan|Toyama-shi, Toyama, Japan|Shimonoseki-shi, Yamaguchi, Japan |
| URL: | https://clinicaltrials.gov/show/NCT01686711 |
